e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure
von der Hardt K., Kandler M.A., Chada M., Cubra A., Schoof E., Amann K., Rascher W., Dotsch J.
Source:
Eur Respir J 2004; 24 : 615-623
Journal Issue:
October
Disease area:
Pulmonary vascular diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
von der Hardt K., Kandler M.A., Chada M., Cubra A., Schoof E., Amann K., Rascher W., Dotsch J.. Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure. Eur Respir J 2004; 24 : 615-623
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Related content which might interest you:
CO2 inhalation attenuates exercise-induced rise of pulmonary artery pressure under acute hypoxia condition
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016
Acute response of iloprost inhalation using the Breelib nebulizer in pulmonary arterial hypertension: the Breelib acute study
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Source: Eur Respir J 2004; 24 : 580-586
Year: 2004
Pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 892-905
Year: 2003
Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
Source: Eur Respir J 2002; 20: 332-338
Year: 2002
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
Source: Eur Respir Rev, 30 (161) 210059; 10.1183/16000617.0059-2021
Year: 2021
Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Inhalation of vasoactive intestinal peptide in pulmonary hypertension
Source: Eur Respir J 2008; 32: 1289-1294
Year: 2008
Pulmonary hypertension in COPD
Source: Eur Respir J 2008; 32: 1371-1385
Year: 2008
Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics
Source: Eur Respir J 2012; 40: 1401-1409
Year: 2012
Pulmonary hypertension in patients with COPD
Source: Eur Respir Mon 2012; 57: 138-147
Year: 2012
Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension
Source: Eur Respir J 2004; 23: 321-326
Year: 2004
Acute pulmonary vasoreactivity to beraprost in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Fitness for flying and diving
Source: Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Year: 2006
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006
Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept